Glycosmedia

Diabetes News Service

Privacy & Cookies: This site uses cookies. By continuing to use this website, you agree to their use.
To find out more, including how to control cookies, see here: Cookies Policy
  • News
  • Archive
  • Categories & Tags
  • Journal Watch
  • Updates
  • Education
  • Reviews
  • About us ▼
    • About Glycosmedia
    • Editorial Team
    • Frequently asked questions
    • Comments
    • Press Releases
    • Disclaimer
  • Subscribe
  • Contact

Diabetes News

Tag: cancer


Trends in predominant causes of death in individuals with and without diabetes in England from 2001 to 2018: an epidemiological analysis of linked primary care records

February 6th 2021

The decline in vascular death rates has been accompanied by a diversification of causes in individuals with diagnosed diabetes and a transition from vascular diseases to cancers as the leading contributor to diabetes-related death. Clinical and preventative approaches must reflect this trend to reduce the excess mortality risk in individuals with diabetes (Lancet Diabetes & Endocrinology)

Categories: News, Pathology
Tags: cancer, mortality

Categories: Pathology
Tags: cancer, mortality

Diabetes Mellitus Increases Risk of Gastric Cancer After Helicobacter pylori Eradication: A Territory-wide Study With Propensity Score Analysis

July 12th 2019

Type 2 DM is associated with an increased risk of GC among patients in whom HP was eradicated, in particular those with gastric cardia cancer and those with suboptimal DM control (Diabetes Care)

Categories: News, Pathology
Tags: cancer, Helicobacter pylori, Type 2 Diabetes

Categories: Pathology
Tags: cancer, Helicobacter pylori, Type 2 Diabetes

Worldwide burden of cancer attributable to diabetes and high body-mass index: a comparative risk assessment

December 5th 2017

A substantial number of cancer cases are attributable to diabetes and high BMI. As the prevalence of these cancer risk factors increases, clinical and public health efforts should focus on identifying optimal preventive and screening measures for whole populations and individual patients (The Lancet Diabetes & Endocrinology)

Categories: News, Pathology
Tags: BMI, cancer

Categories: Pathology
Tags: BMI, cancer

Metformin Improves Overall Survival of Colorectal Cancer Patients with Diabetes: A Meta-Analysis

February 8th 2017

Metformin prolongs the overall survival of diabetic colorectal cancer patients, but it does not affect the colorectal cancer-specific survival. Metformin may be a good choice in treating colorectal cancer patients with diabetes mellitus in clinical settings (Journal of Diabetes Research)

Categories: Medication, News
Tags: cancer, colorectal, metformin

Categories: Medication
Tags: cancer, colorectal, metformin

Use of statins offsets insulin-related cancer risk

November 8th 2016

The use of statins offsets insulin-related cancer risks in patients with diabetes independently of sex and age (Journal of Internal Medicine)

Categories: Medication, News
Tags: cancer, statin

Categories: Medication
Tags: cancer, statin

Use of statins offsets insulin-related cancer risk

October 31st 2016

The use of statins offsets insulin-related cancer risks in patients with diabetes independently of sex and age. Overall, our data support the hyperglycaemia–cancer hypothesis. A reduction in endogenous or exogenous hyperinsulinaemia may be beneficial for cancer prevention. Therefore, insulin-sparing and insulin-sensitizing drugs should be the preferred treatment choices (Journal of Internal Medicine)

Categories: Medication, News
Tags: cancer, statins

Categories: Medication
Tags: cancer, statins

Cancer risk in patients aged 30 years and above with type 2 diabetes receiving antidiabetic monotherapy: a cohort study using metformin as the comparator

September 22nd 2015

Metformin monotherapy may be associated with a reduction in the risk for cancer development compared with sulfonylurea monotherapy. Moreover, the use of an average defined daily dose of >0.25 of metformin when compared to lower dose will contribute to a reduction of 80% risk (Therapeutics and Clinical Risk management)

Categories: Medication, News
Tags: cancer, metformin

Categories: Medication
Tags: cancer, metformin

Use of an α-Glucosidase Inhibitor and the Risk of Colorectal Cancer in Patients With Diabetes: A Nationwide, Population-Based Cohort Study

August 30th 2015

Acarbose use reduced the risk of incident colorectal cancer in patients with diabetes in a dose-dependent manner (Diabetes Care)

Categories: News, Pathology
Tags: acarbose, cancer

Categories: Pathology
Tags: acarbose, cancer

Pioglitazone and bladder cancer risk: a multipopulation pooled, cumulative exposure analysis

April 8th 2015

The cumulative use of pioglitazone or rosiglitazone was not associated with the incidence of bladder cancer in this large, pooled multipopulation analysis (Diabetologia)

Categories: Medication, News
Tags: cancer, pioglitazone, rosiglitazone

Categories: Medication
Tags: cancer, pioglitazone, rosiglitazone

Impact of diabetes type II and chronic inflammation on pancreatic cancer

March 4th 2015

We conclude that diabetes type II has a fundamental influence on pancreatic ductal adenocarcinoma by stimulating cancer cell proliferation, while metformin inhibits cancer cell proliferation (BMC Cancer)

Categories: News, Pathology
Tags: cancer, metformin, Type 2 Diabetes

Categories: Pathology
Tags: cancer, metformin, Type 2 Diabetes

Type 2 diabetes and cancer: umbrella review of meta-analyses of observational studies

January 7th 2015

Though type 2 diabetes has been extensively studied in relation to risk of developing cancer and cancer mortality and strong claims of significance exist for most of the studied associations, only a minority of these associations have robust supporting evidence without hints of bias (BMJ)

Categories: News, Research
Tags: cancer, Type 2 Diabetes

Categories: Research
Tags: cancer, Type 2 Diabetes

Subscribe

subscribe-iconFREE weekly updates by email Please CLICK HERE

Platinum Sponsors

Boehringer Ingelheim Lilly

Gold Sponsors

Napp DiabetesSanofi DiabetesNovo NordiskAstraZeneca

Silver Sponsors

Welsh Endocrinology and Diabetes Society (WEDS)About Ascensia Diabetes CareAbbott Diabetes CareAmgen

FUNDING NOTICE

The Glycosmedia website and newsletter has been made possible with funding support from our sponsors. None of our sponsors have control over the content of the website, newsletter, apps, Twitter feed or RSS newsfeed.

For information about sponsorship and advertising please contact our editor-in-chief Jim Young jim@glycosmedia.com

Advertisers

CRC Press

The organisations advertising in this section do not have any input into, or editorial control over the content of this website.

Categories

  • Audits
  • Bariatric
  • Biochemistry
  • Cardiovascular
  • Devices
  • Diagnosis
  • Diet
  • Education
  • Epidemiology
  • Genetics
  • Gestational
  • Guidance
  • Guidelines
  • Hepatology
  • Hypertension
  • Immunology
  • Management
  • Media
  • Medication
  • Meetings
  • Monitoring
  • Nephrology
  • Neuropathy
  • Nephropathy
  • Obesity
  • Ophthalmology
  • Paediatrics
  • Pathology
  • Pharma
  • Pharmacology
  • Physiology
  • Podiatry
  • Prediabetes
  • Prevalence
  • Prevention
  • Psychological
  • Reports
  • Research
  • Screening
  • Sponsorship
  • Technology
  • Testing
  • Transplantation
  • Treatment
  • Wound Care

To see all articles associated with a category just click on the category name.

Popular Tags

ADA BMI canagliflozin CGM CKD closed-loop COVID-19 dapagliflozin DPP4 Empagliflozin exenatide GLP1 glycaemic control HbA1c heart failure hyperglycemia hypoglycemia incretin insulin insulin pump Insulin resistance Ketoacidosis lada liraglutide metformin microvascular mortality NAFLD NICE pioglitazone pregnancy retinopathy semaglutide SGLT2 inhibitors sitagliptin statin sulfonylureas Type 1 Diabetes Type 2 Diabetes Vitamin D

To see all articles associated with a tag just click on the tag name.

Complete list of Tags ››

Join us on Facebook

Join us on Facebook

Please share Glycosmedia:

Follow us on Twitter

My Tweets

mobileGlycosmedia is also available as an App:

For iPhone and iPad | For Android devices


Sponsorship and Advertising

For information about sponsorship and advertising please contact our editor-in-chief Jim Young jim@glycosmedia.com

Copyright © 2021 Glycosmedia Partnership